Recombinant ALCAM (Praluzatamab Biosimilar) 抗体
适用: 人
FACS, BLI, ELISA, Func, SPR
宿主: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- 抗原
- ALCAM (Praluzatamab Biosimilar)
- 抗体类型
- Recombinant Antibody
- 适用
- 人
-
宿主
-
Human
- Expression System
- CHO Cells
-
克隆类型
- 单克隆
-
标记
- This ALCAM (Praluzatamab Biosimilar) antibody is un-conjugated
- 应用范围
- Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)
- 原理
- Anti-ALCAM / CD166 Reference Antibody (praluzatamab)
- 序列
- QITLKESGPT LVKPTQTLTL TCTFSGFSLS TYGMGVGWIR QPPGKALEWL ANIWWSEDKH YSPSLKSRLT ITKDTSKNQV VLTITNVDPV DTATYYCVQI DYGNDYAFTY WGQGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG ,QGQSGQGLCH PAVLSAWESC SSGGGSSGGS AVGLLAPPGG LSGRSDNHGG SDIVMTQSPL SLPVTPGEPA SISCRSSKSL LHSNGITYLY WYLQKPGQSP QLLIYQMSNL ASGVPDRFSG SGSGTDFTLK ISRVEAEDVG VYYCAQNLEL PYTFGQGTKL EIKRTVAAPS VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
- 产品特性
- Anti-ALCAM / CD166 Reference Antibody (praluzatamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- 纯度
- >95 %
- 亚型
- IgG1
-
anti-ALCAM (Praluzatamab Biosimilar) antibody
Research Grade 适用: 人 FACS 宿主: Humanized Monoclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 说明
-
Therapeutic Agents by Target and Mechanism: CD166 inhibitors
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 浓度
- 1 mg/mL
- 缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- 储存条件
- 4 °C,-80 °C
- 储存方法
- +4°C,-80°C
-
- 抗原
- ALCAM (Praluzatamab Biosimilar)
- 物质类
- Biosimilar
- 分子量
- 145.5 kDa
- UniProt
- Q13740
-
You are here:
